PUBLISHER: The Insight Partners | PRODUCT CODE: 1871528
PUBLISHER: The Insight Partners | PRODUCT CODE: 1871528
The Europe nanoparticle measurement instrument market is projected to grow significantly, reaching approximately USD 2,763.03 million by 2031, up from USD 1,897.58 million in 2023, reflecting a compound annual growth rate (CAGR) of 4.8% from 2023 to 2031.
Executive Summary and Market Analysis
The market is divided into several key regions, including Germany, France, Italy, the UK, Spain, and the Rest of Europe. The growth of the nanoparticle measurement instruments market in Europe is driven by the increasing use of these instruments in disease modeling, gene mutation research, and tumor modeling, alongside a rise in research activities. Additionally, enhanced funding and investments from both public and private sectors are expected to create further opportunities for market expansion in the coming years.
Market Segmentation
The Europe nanoparticle measurement instrument market can be categorized based on type and end user.
By Type: The market includes various instruments such as X-Ray diffractometers, scanning electron microscopes, atomic force microscopes, photon correlation spectroscopy devices, nanoparticle surface area monitors, transmission electron microscopes, condensation particle counters, differential mobility analyzers, scanning mobility particle sizers, nanoparticle tracking analyzers, aerosol particle mass analyzers, and others. Notably, the transmission electron microscope held the largest market share in 2023.
By End User: The market is segmented into the biotechnology sector, pharmaceutical industry, contract research organizations (CROs), and others. The pharmaceutical industry was the leading segment in terms of market share in 2023.
Market Outlook
Research in drug delivery systems utilizing nanotechnology is rapidly advancing. Nanotechnology enhances the effectiveness of treatments for chronic diseases by enabling targeted and site-specific delivery of medications. Various nanomedicine agents are being explored for applications in chemotherapy and immunotherapy. Recent developments focus on improving drug delivery systems through the unique properties of nanomaterials, addressing challenges such as poor bioavailability and suboptimal absorption. For example, lipid nanoparticles (LNPs) are being investigated by AstraZeneca as innovative delivery systems for nucleotide-based therapies that generate therapeutic proteins within target cells. Creative Biolabs is also contributing to this field with advanced formulation development systems for active pharmaceutical ingredients (APIs), offering technologies for polymeric nanoparticles, liposomes, and nanocrystals. Continuous advancements in nanotechnology-based drug delivery systems are anticipated to create substantial opportunities for the nanoparticle measurement instrument market in the future.
Country Insights
The market analysis by country reveals that Germany held the largest share in 2023. Noteworthy events, such as the 3rd Lipid Nanoparticles Development Summit Europe scheduled for September 2024 in Berlin, will gather key players in lipid nanoparticle development, including major companies like GSK, Johnson & Johnson, and CureVac. This summit will address critical challenges in LNP development, such as lipid characterization and targeted delivery, providing a platform for knowledge exchange and innovation in nanomedicine, which could benefit market players in Germany.
In December 2023, researchers from the European Molecular Biology Laboratory (EMBL) Hamburg, Johannes Gutenberg University Mainz, Postnova Analytics GmbH, and BioNTech SE introduced a new analytical method combining asymmetrical-flow field-flow fractionation (AF4) with small-angle X-ray scattering (SAXS) to accurately assess the size, structure, and RNA payload of nanoparticles in pharmaceutical products, particularly focusing on lipoplex formulations.
Additionally, Spectradyne announced a significant increase in the installation of its nCS1 instrument in Germany, which is now being utilized for analyzing exosomes and measuring fluid cleanliness, showcasing the instrument's versatility and precision. The growth of R&D initiatives in nanotechnology, the rising demand for innovative nanoparticle-based drug delivery systems, and the introduction of advanced technologies by market players are key factors propelling the growth of the nanoparticle measurement instrument market in Germany.
Company Profiles
Key players in the nanoparticle measurement instrument market include Bruker, Spectradyne LLC, Malvern Panalytical Ltd, IZON Science LTD, Particle Metrix GmbH, Microtrac Retsch GmbH, Horiba Ltd, Angstrom Advanced Inc., Shimadzu Corp, and Yokogawa Electric Corp. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.